Europe Fluorescent Immunoassay Market
The Europe Fluorescent Immunoassay Market size was valued at US$ 781.27 Mn in 2021 and is projected to reach US$ 1,090.71 Mn by 2028, growing at a CAGR of 4.9% during 2021 - 2028.
Report Coverage
- Product Type: ELISA, Rapid Lateral Flow Immunoassay
- Application: Infectious Diseases, Oncology, Cardiovascular Diseases
- End User: Hospitals & Clinics, Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes
US$ 781.27 Mn
Market size in 2021
US$ 1,090.71 Mn
Market Size by 2028
4.9%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Fluorescent Immunoassay Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Fluorescent Immunoassay Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Fluorescent Immunoassay Market Regional Analysis
6.2 Europe Fluorescent Immunoassay Market Revenue 2019-2028 (US$ Million)
6.3 Europe Fluorescent Immunoassay Market Forecast Analysis
7. Europe Fluorescent Immunoassay Market Analysis – by Product Type
7.1 ELISA
- 7.1.1 Overview
- 7.1.2 ELISA: Europe Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Rapid Lateral Flow Immunoassay
- 7.2.1 Overview
- 7.2.2 Rapid Lateral Flow Immunoassay: Europe Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Europe Fluorescent Immunoassay Market Analysis – by Application
8.1 Infectious Diseases
- 8.1.1 Overview
- 8.1.2 Infectious Diseases: Europe Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Oncology
- 8.2.1 Overview
- 8.2.2 Oncology: Europe Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Cardiovascular Diseases
- 8.3.1 Overview
- 8.3.2 Cardiovascular Diseases: Europe Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Europe Fluorescent Immunoassay Market Analysis – by End User
9.1 Hospitals & Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals & Clinics: Europe Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Diagnostic Centers
- 9.2.1 Overview
- 9.2.2 Diagnostic Centers: Europe Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Pharmaceutical & Biotechnology Companies
- 9.3.1 Overview
- 9.3.2 Pharmaceutical & Biotechnology Companies: Europe Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Academic & Research Institutes
- 9.4.1 Overview
- 9.4.2 Academic & Research Institutes: Europe Fluorescent Immunoassay Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Europe Fluorescent Immunoassay Market – Europe Analysis
10.1 Overview
10.2 Europe- 10.2.1 Europe Fluorescent Immunoassay Market Breakdown, by Key Country, 2022 and 2028 (%)
- 10.2.1.1 Europe Fluorescent Immunoassay Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 UK: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 UK: Europe Fluorescent Immunoassay Market Breakdown, by Product Type
- 10.2.1.1.2 UK: Europe Fluorescent Immunoassay Market Breakdown, by Application
- 10.2.1.1.3 UK: Europe Fluorescent Immunoassay Market Breakdown, by End User
- 10.2.1.2 Germany: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Germany: Europe Fluorescent Immunoassay Market Breakdown, by Product Type
- 10.2.1.2.2 Germany: Europe Fluorescent Immunoassay Market Breakdown, by Application
- 10.2.1.2.3 Germany: Europe Fluorescent Immunoassay Market Breakdown, by End User
- 10.2.1.3 France: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 France: Europe Fluorescent Immunoassay Market Breakdown, by Product Type
- 10.2.1.3.2 France: Europe Fluorescent Immunoassay Market Breakdown, by Application
- 10.2.1.3.3 France: Europe Fluorescent Immunoassay Market Breakdown, by End User
- 10.2.1.4 Russia: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Russia: Europe Fluorescent Immunoassay Market Breakdown, by Product Type
- 10.2.1.4.2 Russia: Europe Fluorescent Immunoassay Market Breakdown, by Application
- 10.2.1.4.3 Russia: Europe Fluorescent Immunoassay Market Breakdown, by End User
- 10.2.1.5 Italy: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.5.1 Italy: Europe Fluorescent Immunoassay Market Breakdown, by Product Type
- 10.2.1.5.2 Italy: Europe Fluorescent Immunoassay Market Breakdown, by Application
- 10.2.1.5.3 Italy: Europe Fluorescent Immunoassay Market Breakdown, by End User
- 10.2.1.6 Rest of Europe: Europe Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Fluorescent Immunoassay Market Breakdown, by Product Type
- 10.2.1.6.2 Rest of Europe: Europe Fluorescent Immunoassay Market Breakdown, by Application
- 10.2.1.6.3 Rest of Europe: Europe Fluorescent Immunoassay Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Abbott
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 BD
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 bioMerieux SA
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Danaher
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Ortho Clinical Diagnostics Holdings plc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Quidel Corporation
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Siemens AG
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Sysmex Corporation
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Thermo Fisher Scientific Inc.
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
